Sonoma Pharmaceuticals Statistics Share Statistics Sonoma Pharmaceuticals has 1.64M
shares outstanding. The number of shares has increased by 22.72%
in one year.
Shares Outstanding 1.64M Shares Change (YoY) 22.72% Shares Change (QoQ) 1.67% Owned by Institutions (%) 2.26% Shares Floating 1.62M Failed to Deliver (FTD) Shares 15,670 FTD / Avg. Volume 24.49%
Short Selling Information The latest short interest is 49.73K, so 3.03% of the outstanding
shares have been sold short.
Short Interest 49.73K Short % of Shares Out 3.03% Short % of Float 4.01% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.79 and the forward
PE ratio is -2.36.
Sonoma Pharmaceuticals's PEG ratio is
0.02.
PE Ratio -0.79 Forward PE -2.36 PS Ratio 0.19 Forward PS 0.3 PB Ratio 0.62 P/FCF Ratio -16.18 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sonoma Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.09,
with a Debt / Equity ratio of 0.07.
Current Ratio 3.09 Quick Ratio 2.38 Debt / Equity 0.07 Debt / EBITDA -0.09 Debt / FCF -1.82 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.43M Profits Per Employee $-345.7K Employee Count 10 Asset Turnover 1.04 Inventory Turnover 3.03
Taxes Income Tax 550K Effective Tax Rate -18.92%
Stock Price Statistics The stock price has increased by -32.96% in the
last 52 weeks. The beta is 1.26, so Sonoma Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.26 52-Week Price Change -32.96% 50-Day Moving Average 3.24 200-Day Moving Average 2.91 Relative Strength Index (RSI) 43.17 Average Volume (20 Days) 63,982
Income Statement In the last 12 months, Sonoma Pharmaceuticals had revenue of 14.29M
and earned -3.46M
in profits. Earnings per share was -2.79.
Revenue 14.29M Gross Profit 5.46M Operating Income -3.71M Net Income -3.46M EBITDA -3.57M EBIT -3.71M Earnings Per Share (EPS) -2.79
Full Income Statement Balance Sheet The company has 5.37M in cash and 305K in
debt, giving a net cash position of 5.07M.
Cash & Cash Equivalents 5.37M Total Debt 305K Net Cash 5.07M Retained Earnings -197.81M Total Assets 13.69M Working Capital 8.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -88K
and capital expenditures -80K, giving a free cash flow of -168K.
Operating Cash Flow -88K Capital Expenditures -80K Free Cash Flow -168K FCF Per Share -0.14
Full Cash Flow Statement Margins Gross margin is 38.25%, with operating and profit margins of -25.97% and -24.2%.
Gross Margin 38.25% Operating Margin -25.97% Pretax Margin -20.35% Profit Margin -24.2% EBITDA Margin -25% EBIT Margin -25.97% FCF Margin -1.18%
Dividends & Yields SNOA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SNOA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 30, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Aug 30, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -19 Piotroski F-Score 3
